It's not at all uncommon for different duration treasury yields to rise and fall at different speeds, creating varied slopes of the yield curve to reflect market conditions. Much more rare is when different duration yields move in entirely opposite directions. Well, in recent weeks, 30-year Treasury yields have risen while shorter term yields have fallen.Pattern last seen in 2001. This shift is driven by a couple interesting factors. First, the Federal Reserve has cut short-term interest rates by 100 basis ...

It's not at all uncommon for different duration treasury yields to rise and fall at different speeds, creating varied slopes of the yield curve to reflect market conditions. Much more rare is when different duration yields move in entirely opposite directions. Well, in recent weeks, 30-year Treasury yields have risen while shorter term yields have fallen.Pattern last seen in 2001. This shift is driven by a couple interesting factors. First, the Federal Reserve has cut short-term interest rates by 100 basis ...

And let's bring in Torston Slock. He is partner and chief economist at Apollo. And Torstston, don't worry.We're not going to ask you to pine on any of the geopolitical stuff. You your job as an economist is to factor in all the costs that we see and establish a conclusion. Here's the reality about the price of oil. We we think about the price of oil when it comes to gasoline.And that's true. About half of a barrel of oil goes into gasoline. But oil goes into a lot of things.Plastics, natural gas, by the way ...

Core Viewpoint - Thermo Fisher Scientific is considering selling part of its diagnostics business due to industry concerns over federal spending cuts on research, with a target sale price of around $4 billion [1][2]. Company Summary - The diagnostics unit of Thermo Fisher produces infectious disease testing equipment and is currently under evaluation for potential sale to private equity firms [2][3]. - The company has experienced a 20% decline in its shares this year, while competitors Danaher and Becton, Dickinson and Company have seen declines of 11% and 23%, respectively [4]. - In the first quarter, Thermo Fisher reported a year-over-year organic revenue growth of 1% [4]. - The CEO of Thermo Fisher expressed pride in the company's strong performance amid a challenging macroeconomic environment [5]. Industry Summary - The healthcare sector is facing volatility due to concerns about the impact of federal budget cuts on research funding, particularly cuts proposed by President Donald Trump to the National Institutes of Health [3]. - Becton, Dickinson and Company announced plans to separate its life sciences business, which includes a diagnostics segment, to enhance focus and value [6][7].

Lael Brainard, Former Federal Reserve vice chair, joins 'Money Movers' to discuss the Israel-Iran conflict, the Fed's next moves and the economy. ...

Senator Baldwin asked you about the legal authority for uh the Marines in my uh state. I disagree with you. I thought not only do I not want Marines in uh Iran, I don't want them in California.But I don't want to get a gotcha. You you know, they said what provision your administration since then has filed in the federal district court. You're arguing that the Marines should be allowed to defend federal property.I disagree with you. That's your argument. Here's where I hope we can agree.Whatever the federal ...

Closer look at the markets here and reaction to the geopolitical news overnight. S&P's down 610 of 1%. Scott Croner joins us, Cityroup US equity strategist.He's here at Post 9. He raised his year-end S&P target to 6,300 this week from 5800. So kind of catching up with the market here, I guess, as we continue to make new highs, although a step back today.Does this how do you think that what happened overnight impacts the US equity market if at all. Yeah, Sarah. So, I I the way we've been talking about it is ...

Market Domination anchors Julie Hyman and Josh Lipton break down the latest financial news for June 12, 2025. The Commodity Futures Trading Commission (CFTC) Acting Chairman Caroline Pham sits down with Yahoo Finance executive editor Brian Sozzi at Coinbase’s State of Crypto Summit to speak more on digital asset regulation under the Trump administration, protecting investors from fraud, and the legitimacy of prediction markets. WM CFO Davina Rankin discusses why she believes trash is a resilient growth busi ...

Core Insights - SoFi Technologies, Inc. (SOFI) has experienced a significant stock price increase of 32% over the past three months and 121.5% over the past year, outperforming the industry growth of 13.8% [1][7] - The company is well-positioned to capitalize on changes in federal student loan policies, which may drive demand for private refinancing options [3] - SoFi's land-and-expand strategy is a key strength, allowing the company to attract a growing customer base and enhance profitability through cross-selling [4] Financial Performance - In Q1 2025, SoFi reported a 20% year-over-year increase in net sales and a remarkable 217% surge in net income, indicating strong operating leverage [10] - The company added 800,000 new members in the quarter, the highest absolute increase recorded, which enhances cross-selling potential [10] - Revenue growth was driven by all three business segments, with Lending and Technology Platform revenues growing 25% and 10% year-over-year, respectively, while the Financial Services segment surged 101% [11] Growth Projections - Management maintains an aggressive revenue growth outlook for 2025, projecting a revenue increase of 24% to 27% and an EPS surge of 80% to 87% [5][8] - The Zacks Consensus Estimate for SOFI's 2025 earnings is 27 cents per share, reflecting an 80% year-over-year increase, with projected revenues of $3.29 billion, marking a 26.2% increase from the previous year [11] Market Position and Competitive Landscape - Galileo, SoFi's B2B financial services platform, is a pivotal growth driver, with the embedded finance market projected to grow at a 16.8% CAGR through 2029 [9] - SoFi's ability to attract high-profile clients through Galileo strengthens its long-term outlook and market position [9] Valuation Concerns - SOFI's forward P/E ratio of 40.03 significantly exceeds the industry average of 18.63, raising concerns about valuation sustainability [7][17] - The elevated valuation suggests that investors are pricing in aggressive growth expectations that may not be fully supported by current fundamentals [17]

Core Insights - WidePoint Corporation (WYY) shares have decreased by 43.5% over the past month, underperforming the Zacks Computer - Services industry, which rose by 0.6%, and the broader S&P 500, which grew by 2.5% [1][2] Financial Performance - The decline in stock price follows weaker-than-expected Q1 2025 results, with a reported loss of 8 cents per share, missing the Zacks consensus estimate of a loss of 1 cent. Revenues were $34.2 million, falling short by approximately $5 million [10][12] - A $2.7 million accounting adjustment related to reselling contracts negatively impacted reported revenues, causing confusion around growth trends [11] - Cash reserves have dropped to $3.7 million due to delayed payments from a major customer, raising short-term liquidity concerns [12] Market Position and Strategic Developments - WidePoint has secured three task orders under the $2.7 billion Spiral 4 contract, with expectations for increased activity in H2 2025 [7][17] - The company achieved FedRAMP authorization for its Intelligent Technology Management System (ITMS), enhancing its position with federal agencies [16] - WidePoint is also investing in commercial growth opportunities, including its Device-as-a-Service (DaaS) offering and early-stage smart city initiatives [18][19] Valuation and Analyst Sentiment - WYY stock is trading at a forward 12-month price-to-sales (P/S) multiple of 0.19X, significantly below the industry average of 1.82X, indicating a potentially attractive investment opportunity [20] - Analysts maintain a bullish outlook, with an average price target of $7.50, suggesting a potential upside of 126.6% from the last closing price of $3.31 [23][24] Investment Considerations - Despite strategic progress, near-term challenges such as the recent earnings miss, accounting adjustment, and declining cash reserves present executional risks [25] - Investors are advised to monitor the company's ability to convert pipeline opportunities into revenue and improve liquidity before making new investments [26]